Tenaya Therapeutics Statistics
NASDAQ: TNYAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.5803+0.0361 (+6.63%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tenaya Therapeutics by the numbers
Tenaya Therapeutics has a market capitalization of $130.1 million based on 224.23M shares outstanding. With trailing EPS of $-0.56, Tenaya Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.8% below its 50-day average and 21.2% below its 200-day average.
Average daily trading volume is 2.27M shares, or about $1.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TNYA valuation vs. peer median
| Metric | TNYA | Peer median | Difference |
|---|---|---|---|
| Market cap | $130.12M | $136.54M | -5% |
| Avg. volume | 2.27M | 790.89K | +186% |
Peer median across 8 companies: ARMP, AVXL, ENGN, LENZ, MOLN, HUMA, CRDL, VYGR.
Valuation
- Market cap
- $130.12M
- EPS (TTM)
- $-0.56
- Shares outstanding
- 224.23M
Price and trading
- Previous close
- 0.5442
- Open
- 0.539
- Day range
- 0.5385 – 0.59
- 52-week range
- 0.521 – 2.35
- 52-week change
- -71.27%
- 50-day moving average
- 0.6731
- Beta
- —
- Volume
- 4.25M
- Average volume
- 2.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 130.12M
- Forward Pe
- -1.48
- Eps
- -0.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.35
- Week52 Low
- 0.52
- Avg Volume
- 2.27M
- Shares Outstanding
- 224.23M
- Ma50
- 0.67
- Ma200
- 0.74
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -75.31%
- Pct From52w Low
- 11.38%